Experience

StubHub Announces $800 Million IPO

September 18, 2025

Cooley advised the underwriters of StubHub Holdings, a global secondary ticketing marketplace for live events, in connection with StubHub’s $800 million initial public offering (IPO).

Read more

Related contacts

David Peinsipp
Partner, San Francisco
Kristin VanderPas
Partner, San Francisco
Denny Won
Partner, San Francisco
Shannon Eagan
Partner in Charge – Palo Alto, Palo Alto
Adam Fleisher
Partner, Washington, DC
Charlie Kim
Partner, San Diego
Kevin King
Partner, Washington, DC
Xander Lee
Partner, Santa Monica
James Maton
Co-Partner in Charge – London, London
Barbara Mirza
Partner, Santa Monica
John Paul Oleksiuk
Partner, New York
Obrea Poindexter
Partner, Washington, DC
Francis Wheeler
Senior Counsel, Colorado
Chris Chynoweth
Special Counsel, New York
Sharon Connaughton
Special Counsel, Washington, DC
David Hopkins
Special Counsel, Colorado
Andrew Linch
Special Counsel, London
Kimberly Nguyen
Special Counsel, Reston
Randy Sabett
Special Counsel, Washington, DC
Karen Tsai
Special Counsel, Washington, DC
Peter Burns
Of Counsel, Palo Alto
Chelsea André
Associate, Colorado
Jasmine A. Banks
Associate, Washington, DC
Peter A. Haddad
Associate, San Diego
David D. Kim
Associate, San Francisco
Dana N. Levin
Associate, New York
Isabelle Mackesey
Associate, Reston
Liz Paisner
Associate, New York
Erica Russell
Associate, San Francisco
Valerie Sapozhnikova
Associate, Los Angeles
Patrick Sharma
Associate, Santa Monica
Ryan Sim
Associate, San Francisco
Arda Can Tekin
Associate, London
Lawrence Traylor
Associate, Santa Monica
Genevieve Lim Urban
Associate, Seattle
Veronica Cortes
Paralegal Specialist, New York
Melissa Eskola
Paralegal Specialist, Reston
Margie Murphy
Paralegal Specialist, New York
Douglas Lyles
Senior Research Services & Access Analyst

Related Practices & Industries

Upstream Bio Announces Upsized $293 Million IPO

October 15, 2024

Cooley advised the underwriters of Upstream Bio, a clinical-stage biotech developing a monoclonal antibody to target respiratory disorders, on its upsized $293 million initial public offering.

Read more

Related contacts

Kristin VanderPas
Partner, San Francisco
David Peinsipp
Partner, San Francisco
Denny Won
Partner, San Francisco
Charlie Kim
Partner, San Diego
Claire Keast-Butler
Co-Partner in Charge – London, London
Xander Lee
Partner, Santa Monica
Barbara Mirza
Partner, Santa Monica
Phil Mitchell
Partner, New York
Dr. Madhuri Roy
Partner, Palo Alto
Francis Wheeler
Senior Counsel, Colorado
Rebecca Ross
Special Counsel, Washington, DC
Randy Sabett
Special Counsel, Washington, DC
Natasha Leskovsek
Of Counsel, Washington, DC
Megan Drill
Associate, San Diego
Zack Gong
Associate, Shanghai
Peter A. Haddad
Associate, San Diego
David D. Kim
Associate, San Francisco
Jessica Koffel
Special Counsel, Brussels
Sarah Miller
Associate, New York
Lawrence Traylor
Associate, Santa Monica

Related Practices & Industries

Founders Fund Co-Leads Anduril’s $1.5 Billion Series F

August 7, 2024

Cooley advised Founders Fund, a venture capital firm investing in smart people solving difficult problems, as a co-lead investor in Anduril Industries’ $1.5 billion Series F funding round, which increased Anduril’s valuation to $14 billion.

Read more

Related contacts

Peter H. Werner
Partner in Charge – San Francisco, San Francisco
Jamin Agosti
Associate, San Francisco
Umer Chaudhry
Associate, Washington, DC
David Fletcher
Partner, Washington, DC
Grant Schweikert
Special Counsel, Washington, DC
Blake Martell
Of counsel, San Francisco
Annie Froehlich
Partner, Washington, DC
Christopher Kimball
Partner, Washington, DC
Brendan Hughes
Co-Partner in Charge – Washington, DC, Washington, DC
Rebecca Givner-Forbes
Special Counsel , Washington, DC
Sharon Connaughton
Special Counsel, Washington, DC
David D. Kim
Associate, San Francisco
Anisha Mohin
Associate, New York
Amis Pan
Associate, Palo Alto
Greg Reith
Associate, Washington, DC
Veronica Cortes
Paralegal Specialist, New York
Michael Suyat
Senior Paralegal, San Francisco
Katie Kissner
Quantitative Analyst, San Francisco

Related Practices & Industries

Vaxcyte Announces $862.5 Million Public Offering

February 5, 2024

Cooley advised Vaxcyte, a clinical-stage vaccine innovation company, on its $862.5 million follow-on public offering.

Read more

Related contacts

John McKenna
Partner, Palo Alto
Mark Weeks
Partner, Palo Alto
David D. Kim
Associate, San Francisco
Victoria Comesañas
Associate, Los Angeles
Megan Stallworth
Associate, Palo Alto
Charlie Kim
Partner, San Diego
Phil Mitchell
Partner, New York
Natasha Leskovsek
Of Counsel, Washington, DC
Wyatt Kernell
Associate, Colorado
Mika Reiner Mayer
Partner, Palo Alto
Kimberly Bolin
Patent Agent, Palo Alto
Eileen Marshall
Partner, Washington, DC
Mark Windfeld-Hansen
Senior Counsel, Palo Alto
Francis Wheeler
Senior Counsel, Colorado

Related Practices & Industries

Sagimet Biosciences – $112.5 Million Follow-On Offering

January 30, 2024

Cooley advised the underwriters in Sagimet Biosciences’ $112.5 million follow-on offering. Goldman Sachs, TD Cowen and Leerink Partners acted as joint book-running managers for the offering. JMP Securities is acting as lead manager for the offering. Sagimet Biosciences’ is a clinical-stage biopharmaceutical company developing novel fatty acid synthase inhibitors designed to target dysfunctional metabolic pathways in diseases resulting from the overproduction of the fatty acid palmitate. Partners John McKenna, Natalie Karam and Denny Won led the Cooley team.

Related contacts

John McKenna
Partner, Palo Alto
Denny Won
Partner, San Francisco
David D. Kim
Associate, San Francisco
Nicholas Yacoubian
Associate, Palo Alto
Victoria Comesañas
Associate, Los Angeles

Related Practices & Industries

View more

Admissions and credentials

California

New York

This content is provided for general informational purposes only, and your access or use of the content does not create an attorney-client relationship between you or your organization and Cooley LLP, Cooley (UK) LLP, or any other affiliated practice or entity (collectively referred to as "Cooley"). By accessing this content, you agree that the information provided does not constitute legal or other professional advice. This content is not a substitute for obtaining legal advice from a qualified attorney licensed in your jurisdiction, and you should not act or refrain from acting based on this content. This content may be changed without notice. It is not guaranteed to be complete, correct or up to date, and it may not reflect the most current legal developments. Prior results do not guarantee a similar outcome. Do not send any confidential information to Cooley, as we do not have any duty to keep any information you provide to us confidential. When advising companies, our attorney-client relationship is with the company, not with any individual. This content may have been generated with the assistance of artificial intelligence (Al) in accordance with our Al Principles, may be considered Attorney Advertising and is subject to our legal notices.